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Attempts to Improve Hepatitis C
Screening Rates in a
Gastroenterology Fellows’ Clinic:
a quality improvement initiative
Alexander Weick, MD
Andrew Watson, MD
Reena Salgia, MD

Introduction
• CDC recommends one-time birth cohort Hepatitis C (HCV) testing for
individuals born between 1945-1965.
• Previous quality improvement (QI) projects aiming to improving HCV
screening have largely focused on increasing education of screening
guidelines.
• We conducted a QI initiative focusing on improving the rates of HCV
birth cohort screening in the Gastroenterology Fellows’ (GI) continuity
clinic at an urban tertiary care center.

Methods
• The baseline rates of HCV birth cohort screening were assessed for
patients seen in GI Fellows’ clinic within three months prior to our
intervention.
• The intervention was a standardized documentation statement to be
included in all fellows’ electronic medical record clinic notes to allow
for clear documentation of the patients’ HCV status.
• Total span of data collection was 6 months from July 1, 2017 through
December 31, 2017

Methods
• The primary aim of this study was to assess the impact of this
intervention on age-appropriate HCV screening achieved within three
months after the intervention.
• The secondary aim was to compare baseline HCV screening rates in
this urban population of patients.

Results
• 231 patients in the pre-intervention group
• 45.1% of patients were male and 23.4% were Caucasian.

• 245 patients in the post-intervention group
• Median age for both groups was 63 (average year of birth 1955).
• In the post-intervention group, 42.4% were male and 18.8% were Caucasian.

Results
• 92 of 231 (39.8%) patients in the pre-intervention group and 80 of
245 (32.7%) patients in the post-intervention group had NOT received
screening for HCV prior to GI clinic appointment .
• 11 of the 92 (12.0%) patients in the pre-intervention group who had
lacked prior screening were appropriately screened at their clinic
appointment, compared to 12 of 80 (15.0%) in the post-intervention
group.
• There was no significant difference between the groups (p=0.559)

Pre-Intervention Post-Intervention
Prior HCV Screening

60.2%

67.3%

GI Clinic Screening

12.0%

15.0%

Conclusions
• This quality improvement intervention did show unexpectedly high
baseline HCV birth cohort screening rates compared to recent
published reports.
• Literature-reported rates of HCV screening ranging from 0.68% to 37%
• This is may be partially due to the hospital system’s EMR incorporating
electronic alerts for age-based HCV screening.

• This specific intervention did not show a significant improvement in
hepatitis C viral screening rates in the GI fellows’ continuity clinic.

Conclusions
• The lack of efficacy with this intervention is relevant to allow future
alternative approaches for improving screening rates to be explored.
• Interventions focused on adding documentation for improving
screening rates may be onerous for GI clinicians who are seeing
patients for primarily non-hepatologic concerns.
• Our study highlights the need for further quality improvement studies
to continue to improve birth cohort HCV screening rates to a goal of
100 percent among GI physicians.

